IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
AstraZeneca's forecasts show an “urgent and growing” global health situation that has “profound economic and environmental implications.”
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers.
EU regulator rules out link between weight-loss drugs and suicidal thoughts
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
AstraZeneca’s rare disease arm Alexion is debuting an original short film Thursday for patients with the rare neurological condition neuromyelitis optica spectrum disorder (NMOSD).
AstraZeneca has suffered a shareholder rebellion against an £18.7m pay packet for the pharmaceutical company’s chief executive, Pascal Soriot, with more than a third of votes cast opposing the deal.
Despite rebellion, approval of £18.7m package opens door to likelihood of US-style executive pay elsewhere
April 11 (Reuters) - Drugmaker AstraZeneca (AZN.L) , opens new tab plans to raise its annual dividend by 7% for 2024, it said on Thursday, ahead of a shareholder vote on a hefty boost to its Chief Executive's pay package